Basic Advagraf Information

• INN (International Nonproprietary Name): Tacrolimus
• Brand Names Available In Canada (English): Prograf®, Advagraf®, Envarsus XR®, Modigraf®, generic tacrolimus (brands such as Tacrolimus Sandoz®, Tacrolimus Mylan®)
• ATC Code: L04AD02
• Forms & Dosages: Immediate-release capsules 0.5mg, 1mg, 5mg; Granules for oral suspension 0.2mg and 1mg sachets; Injection (IV) 5mg/mL vials; Extended-release tablets/capsules 0.5mg, 1mg, 3mg, 5mg
• Manufacturers In Canada (English): Global suppliers include Astellas Pharma, Sandoz, Mylan, Accord, Teva, Cipla; Local manufacturers: not specified
• Registration Status In Canada (English): not specified
• OTC / Rx Classification: Rx only

Why Patients Ask About Advagraf

What will this medicine do for me after a transplant?

Advagraf is an extended‑release formulation of tacrolimus used to prevent organ rejection in transplant recipients.

Patients often ask whether Advagraf is the same as Prograf or generic tacrolimus.

Advagraf contains the same active ingredient, tacrolimus, but is formulated for once‑daily dosing which differs from immediate‑release tacrolimus capsules used twice daily.

People worry about side effects such as kidney problems, tremors, or new diabetes after transplant.

Blood monitoring and dose adjustments are the key steps to reduce those risks.

How Advagraf Works

Advagraf is a calcineurin inhibitor that suppresses the immune response that causes organ rejection.

Tacrolimus reduces T‑cell activation by inhibiting calcineurin activity.

Lowering T‑cell activity helps the body tolerate a transplanted kidney, liver, heart, or lung.

Because it suppresses immune function, long‑term therapy increases the risk of infections and some malignancies.

Blood trough levels must be measured regularly to balance prevention of rejection with minimization of toxicity.

Who Uses Advagraf And When

Advagraf is prescribed for adults who need long‑term immunosuppression after organ transplantation.

Typical indications include kidney, liver, heart, and lung transplants where tacrolimus is part of a combination regimen with steroids and antimetabolites.

Children may receive tacrolimus but often need higher mg/kg doses and closer monitoring due to faster metabolism.

Elderly patients are started at lower doses and monitored carefully for toxicities.

Standard Dosage Guidance

What dose should I expect after transplant?

Initial dosing depends on the transplanted organ and the patient’s weight and hepatic function.

For kidney transplant adults, typical initial oral dosing is 0.1–0.2 mg/kg/day divided every 12 hours for immediate‑release formulations.

Liver transplant dosing commonly starts at 0.10–0.15 mg/kg/day divided every 12 hours.

Target trough levels vary by time since transplant and organ type, often 5–15 ng/mL early after transplant, then lower maintenance targets such as 3–7 ng/mL for kidneys.

Advagraf is formulated for once‑daily dosing but doses must be individualized to trough levels and clinical response.

Monitoring And Dose Adjustments

Why are blood levels needed?

Tacrolimus has a narrow therapeutic window and variable absorption between people.

Regular trough (pre‑dose) monitoring is required to guide dose adjustments and avoid nephrotoxicity or rejection.

Adjustments are needed for children, patients with liver impairment, and those taking interacting medications.

Renal impairment does not mandate an automatic dose reduction, but close monitoring is essential because tacrolimus itself can be nephrotoxic.

Important Safety Considerations

What are the common side effects to expect?

Common adverse effects include tremor, headache, nausea, diarrhea, hypertension, and insomnia.

Abnormal kidney function and elevated creatinine are important consequences to watch for during therapy.

Tacrolimus can cause hyperglycemia and raise the risk of new‑onset diabetes after transplant.

Serious risks include severe infections and an increased risk of lymphomas or other malignancies due to immunosuppression.

Absolute contraindications include known hypersensitivity to tacrolimus or related macrolide immunosuppressants.

Drug Interactions And Cautions

Which medicines raise or lower tacrolimus levels?

Many drugs modify tacrolimus metabolism or kidney function and require dose changes or monitoring.

Concurrent nephrotoxic drugs increase the risk of kidney injury when used with tacrolimus and should be used with caution.

Because tacrolimus is metabolized by hepatic enzymes, potent enzyme inducers or inhibitors can change tacrolimus blood levels.

Always inform the transplant team of antibiotics, antifungals, anticonvulsants, or herbal supplements you plan to use.

Formulations And Switching Advice

Advagraf is an extended‑release formulation intended for once‑daily use.

Immediate‑release tacrolimus capsules such as Prograf are typically given twice daily.

Formulations are not interchangeable without medical supervision.

Do not switch from immediate‑release to extended‑release tacrolimus or vice versa without a clinician’s plan and new therapeutic drug monitoring.

Granules for oral suspension are available for patients who cannot swallow capsules.

Practical Administration Tips

Take Advagraf whole and at the same time each day to keep blood levels consistent.

Do not crush or chew extended‑release tablets or capsules unless the product information explicitly allows it.

If using granules for oral suspension, follow reconstitution and administration steps provided by the pharmacist or prescriber.

If a dose is missed, take it as soon as remembered if a few hours remain before the next scheduled dose.

If near the next dose, skip the missed dose and resume the regular schedule; never take a double dose.

Storage And Transport

How should Advagraf be stored?

Capsules and granules should be stored at 20–25°C (68–77°F) and kept away from moisture and light.

Do not refrigerate standard capsules or granules unless the manufacturer instructs otherwise.

Injection vials should be stored according to the manufacturer’s instructions and not frozen.

Maintain temperature control during transport to preserve product stability.

Access, Ordering, And Cost Considerations

How can patients obtain Advagraf in Canada?

Advagraf is an Rx product and normally requires a prescription from a transplant centre or specialist.

Some branded and generic tacrolimus products are supplied through hospital pharmacies and specialty distributors.

In our online pharmacy, advagraf is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Always confirm the prescribed product and strength with your transplant team before ordering.

Choosing Between Brands And Generics

Patients often ask whether Prograf, Advagraf, or a generic is "better."

All contain tacrolimus as the active ingredient, but release profiles and formulation excipients differ.

Advagraf is designed for extended release and once‑daily dosing, while Prograf is immediate‑release and given twice daily.

Generic tacrolimus preparations are widely available and can be used according to national guidelines and hospital protocols.

Any change in brand or formulation should be coordinated with therapeutic drug monitoring to confirm equivalent blood levels.

Topical Tacrolimus Versus Systemic Use

Is tacrolimus the same in ointment form?

Topical tacrolimus (marketed as Protopic ointment) is a different formulation intended for dermatologic use and not for transplant immunosuppression.

Do not confuse topical products with systemic formulations such as Advagraf or Prograf.

Topical tacrolimus has different dosing, risks, and indications and is not interchangeable with oral or injectable tacrolimus.

Common Patient Questions

Can tacrolimus cause tremors and how are they managed?

Tremor is a common side effect that may improve with dose adjustments guided by trough levels.

What should I do if my creatinine rises on tacrolimus?

Elevations in creatinine require prompt discussion with the transplant team as dose reduction or alternative strategies may be needed.

Can tacrolimus lead to diabetes?

Yes, tacrolimus can cause hyperglycemia and increase the risk of post‑transplant diabetes, so blood glucose should be monitored.

When To Seek Urgent Help

Seek urgent medical assessment for signs of severe infection, marked changes in urine output, sudden confusion, or seizures.

Overdose can cause marked nephrotoxicity, neurotoxicity, and hyperkalemia and requires immediate care.

Notify the transplant team promptly if you develop high fever, severe sore throat, or unexpected bruising or bleeding.

Patient Example

A 45‑year‑old kidney transplant recipient called on a Friday night about a missed dose and a headache.

The simple advice was to take the next dose at the regular time and avoid doubling up, and to contact the transplant pharmacist the next working day for a possible trough check.

This example shows the importance of therapeutic drug monitoring and clear missed‑dose instructions.

Frequently Asked Questions

1. How Long Will I Need Tacrolimus?

   Most transplant recipients require long‑term, often lifelong, tacrolimus therapy to prevent organ rejection.

2. Can I Drink Alcohol While Taking Tacrolimus?

   There is no specific prohibition in the product information, but alcohol can affect blood pressure and blood glucose and should be discussed with the transplant team.

3. Are Advagraf And Prograf Interchangeable?

   No. Formulations are not interchangeable without medical supervision and monitoring because release profiles and dosing frequency differ.

4. What If I Am Planning Pregnancy?

   Tacrolimus has important implications for pregnancy and breastfeeding and must be discussed with transplant specialists before conception or treatment changes.

Summary And Next Steps

Advagraf is an extended‑release tacrolimus formulation used to prevent organ rejection in transplant recipients.

It requires prescription oversight, regular trough monitoring, and careful attention to side effects and interacting medications.

Formulations such as immediate‑release tacrolimus capsules, granules, and injections exist and are used according to patient needs.

Coordinate any brand or formulation change with the transplant team and confirm dosing via therapeutic drug monitoring.

Delivery Across Canada (English)

Final Notes For Patients

Keep all transplant clinic appointments and lab checks as scheduled because tacrolimus dosing relies on trough monitoring.

Report side effects such as tremor, decreased urine output, fever, or unexplained bruising promptly.

Do not stop or change tacrolimus dosing without direct instruction from your transplant team.

If ordering through an online pharmacy, confirm product identity and strength and keep a record of batch numbers and expiry dates.

Discuss any questions about switching between Advagraf, Prograf, or generic tacrolimus with your specialist pharmacist or transplant physician.

Safe and effective use of tacrolimus depends on coordinated care, monitoring, and clear communication between patient and healthcare providers.